ClinicalTrials.gg

Program

ABBV-701

A development code.

Its studies are mostly in Arthritis, Psoriatic · Crohn Disease, led by AbbVie.

Furthest: phase 2, since Mar 4, 20253 company-led studies, 3 open or runningNext primary completion: Nov 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AbbVie33 open or runningphase 2since Mar 4, 2025Mar 4, 2025Nov 2026phase 1 · NCT06895343

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 4, 2025First study: phase 2 study in Arthritis, PsoriaticFirst studyNCT06865105 · 300 planned · United States, Canada, Czechia and more
  2. Mar 20, 2025Phase 1 study in Healthy VolunteerNCT06895343 · 100 enrolled · United States
  3. Jul 7, 2026Phase 2 study in Crohn DiseaseNCT07697456 · 2,000 planned · United States, Canada, Israel and more
  4. Nov 9, 2026Primary completion moved from 2027-12 to 2029-08Date moved laterphase 2 · +20 months · NCT06865105

Ahead

  1. Nov 2026Primary completion: phase 1 study in Healthy VolunteerNCT06895343
  2. Aug 2029Primary completion: phase 2 study in Arthritis, PsoriaticNCT06865105
  3. Oct 2031Primary completion: phase 2 study in Crohn DiseaseNCT07697456

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07697456Crohn Disease · United States, Canada, Israel and more2RecruitingOct 20312,000
NCT06895343Healthy Volunteer · United States1Active, not recruitingNov 2026100
NCT06865105Arthritis, Psoriatic · United States, Canada, Czechia and more2RecruitingAug 2029300

How it is read

Names in the registry

  • “ABBV-701”, 4 entries

Codes read as this program: ABBV701.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.